series-a
Stage
2
Investors
About
Lifordi Immunotherapeutics is a clinical-stage biotech company developing antibody-drug conjugates (ADCs) that target immune cells to treat autoimmune and inflammatory disorders with precision.
Explore Lifordi Immunotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.